Literature DB >> 7509983

[125I]-endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis.

M R Dashwood1, S G Barker, J R Muddle, M H Yacoub, J F Martin.   

Abstract

The distribution of [125I]-endothelin-1 (ET-1) binding sites on human and porcine vessels was studied with in vitro receptor autoradiography. Binding to normal human saphenous veins was compared to atheromatous veins used as coronary artery bypass grafts. Binding to porcine vessels, from an experimental model of intimal hyperplasia, was also studied. There was dense binding of [125I]-ET-1 to smooth muscle of all vessels examined, as well as to the vasa vasorum and regions of neovascularization of diseased vessels. Binding to microvasculature (vasa vasorum and regions of neovascularization) is of particular interest, because ET-1 has been shown to have mitogenic activity on vascular smooth-muscle cells in culture and microvessels are extremely sensitive to the constrictor effect of ET-1. Binding of [125I]-ET-1 to vasa vasorum of normal blood vessels and to regions of neovascularization of atheromatous vessels suggests that ET-1 plays a pathophysiologic role in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509983     DOI: 10.1097/00005344-199322008-00090

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Elevations in C-reactive protein and endothelin-1 system activity in humans.

Authors:  Caitlin A Dow; Danielle L Templeton; Grace M Lincenberg; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Life Sci       Date:  2015-12-11       Impact factor: 5.037

2.  Endothelin-1 and its receptors on haemorrhoidal tissue: a potential site for therapeutic intervention.

Authors:  Varut Lohsiriwat; John H Scholefield; Vincent G Wilson; Michael R Dashwood
Journal:  Br J Pharmacol       Date:  2017-02-16       Impact factor: 8.739

3.  Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology.

Authors:  R Scotland; P Vallance; A Ahluwalia
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis.

Authors:  Myeong Ho Yoon; Martin Reriani; Gössl Mario; Charanjit Rihal; Rajiv Gulati; Ryan Lennon; Jonella M Tilford; Lilach O Lerman; Amir Lerman
Journal:  Int J Cardiol       Date:  2013-01-03       Impact factor: 4.164

5.  The effect of the ETA receptor antagonist, FR 139317, on [125I]-ET-1 binding to the atherosclerotic human coronary artery.

Authors:  M R Dashwood; S P Allen; T N Luu; J R Muddle
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

Review 6.  Vasa vasorum in atherosclerosis and clinical significance.

Authors:  Junyan Xu; Xiaotong Lu; Guo-Ping Shi
Journal:  Int J Mol Sci       Date:  2015-05-20       Impact factor: 5.923

7.  Nerve-perivascular fat communication as a potential influence on the performance of blood vessels used as coronary artery bypass grafts.

Authors:  Andrzej Loesch; Michael R Dashwood
Journal:  J Cell Commun Signal       Date:  2017-06-10       Impact factor: 5.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.